Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...

Whether you're navigating capacity planning, considering a CDMO partnership, or tracking innovation in manufacturing, this conversation offers valuable insights into where the market is headed. 1.

If you’re a new homeowner dreaming about overhauling your outdoor space, or want to spruce up your backyard but haven’t had time, maybe you’re ready to hire a landscape designer.

Competitive Landscape Analysis The global nutraceutical CDMO market is marked by the presence of established and emerging market players such as Catalent Inc.; Lonza; NutraScience Labs; Robinson ...

As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading global CRO and scientific advisory partner has published a new white paper ...

The U.S. Small Molecule Innovator API CDMO Market offers growth opportunities fueled by rising demand for HPAPIs across ...

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter“Fujirebio”) today announced that ...

According to market.us, the Global Biologics CDMO Market Size is expected to be worth around US$ 84.9 Billion by 2034, growing at a CAGR of 15.7% between 2025 to 2034.